Alan Clyde Hayes Savage, Director at Pacgen Life Science, holds 14.62M shares in Innovotech (Ticker: TSE:IOT), holds 5.40M shares in Pacgen Life Science (Ticker: TSE:PBS), holds 2.03M shares in Prime Mining (Ticker: PRMNF). Most recently, Alan Clyde Hayes Savage Bought ― shares of Innovotech on Nov 06, 2024 for an estimated value of 100.00K.
What is the percentage of profitable transactions made by Alan Clyde Hayes Savage?
The percentage of profitable transactions made by Alan Clyde Hayes Savage is 68%.
What is the average return per transaction made by Alan Clyde Hayes Savage?
The average return per transaction made by Alan Clyde Hayes Savage is 47.90%.
What stocks does Alan Clyde Hayes Savage hold?
Alan Clyde Hayes Savage holds: TSE:PBS, TSE:IOT, TSE:EBN, TSE:ARC, TSE:ARD, TSE:WBE, PRMNF stocks.
What was Alan Clyde Hayes Savage’s latest transaction?
Alan Clyde Hayes Savage latest transaction was an Informative Buy of C$100.00K.
What was Alan Clyde Hayes Savage's most profitable transaction?
Alan Clyde Hayes Savage’s most profitable transaction was an Informative Buy of PRMNF stock on October 20, 2017. The return on the trade was 478.20%.
What is Alan Clyde Hayes Savage's role in Pacgen Life Science?
Alan Clyde Hayes Savage's role in Pacgen Life Science is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.